Why the Examiner Matters: How One Reviewer Shapes Time and Cost

A patent owner's defense cost in utility-patent ex parte reexamination depends less on the procedure than on the examiner running it. (Profile of the broader USPTO reexam examiner population.) Across the 110+ active USPTO reexam examiners, pendency, office action count, and appeal rate vary by enough to change the realistic cost projection by 2x or more. The procedural framework is uniform. The examiner is not. This is a closer look at how much one variable can move the case.

The variance, quantified

Across 4,521 closed reexams since 2012, three operational metrics show wide examiner-level variance:

• Pendency: Average 17.4 months. Individual examiner averages range from approximately 12 months on the fast end to over 24 months on the slow end. A 2x spread.
• Office actions per reexam: Index average 1.5. Individual averages range from approximately 1.0 (single OA, no repeat) to 2.5+ (multi-action sequence). Roughly a 2.5x spread.
• PTAB appeal rate: Index average 24%. Individual examiner rates range from approximately 10% to 50%. About a 5x spread.

These are not edge cases. They are the routine variance across the active population.

Peter C. English as a case study

The clearest illustration is Peter C. English. 114 reexams handled since 2012, the highest single-examiner volume. Closed: 88. Open: 26.

The English profile against the average:

What this means in practice for a patent owner with a reexam assigned to English:

• The realistic timeline is roughly five months longer than the average, about two years from filing to final disposition.
• The expected office action sequence runs 2.2 actions, not 1.5. That is one additional round of responses, prosecution work, and amendment consideration.
• The probability of a PTAB appeal is roughly 50/50, against the 24% index rate. The base case cost projection should include appeal costs.
• The 92% cert rate is close to the 94% average, so the procedural outcome is comparable. The path is just longer.

Why examiners produce different patterns

Three factors plausibly explain the examiner-level variance:

First, rejection-basis preference. Examiners who reach a wider range of statutory grounds (more 102 and 112 alongside 103) tend to develop more substantive office actions, which lengthens the action sequence. Examiners who consistently reach 103 alone often resolve cases faster.

Second, amendment posture. Some examiners accept narrowing claim amendments readily and close cases on amended claims. Others push back on amendments and develop the record further, sometimes through additional rejections, sometimes through final-rejection sequences that prompt appeals.

Third, technology area and case complexity. Examiners specialize in specific technology areas. Some technologies produce inherently more complex prosecution sequences (multi-claim software patents, biotech with detailed specification challenges, etc.). Examiner-level metrics reflect both the examiner's tendencies and the technology mix they handle.

For practitioner purposes, the cause matters less than the effect: assignment to a high-variance examiner reshapes the realistic case forecast.

What this means for case strategy

Three operating implications:

1. The base case forecast should be examiner-conditioned, not index-conditioned. A pendency estimate built on the 17.4-month index average is wrong for half the active examiners. Forecasts should use the assigned examiner's actual pattern.

2. PTAB appeals are not always a fail state. For an examiner whose case load runs through the PTAB in nearly half of dispositions, appeal is part of the procedure's normal flow. Treating it as exceptional misframes the strategic conversation with the client.

3. The examiner's office action style shapes the response strategy. Examiners who develop substantive 112 rejections respond differently to specification-grounded arguments than examiners who almost never reach 112. Patent owner statements should anticipate the examiner's likely grounds, not just the requester's.

The procedure is one variable. The examiner is the bigger one. The 2x-to-5x spreads in pendency, action count, and appeal rate translate directly to the cost and complexity of the case. Knowing your examiner is most of the strategic edge available in the procedure.